Valuation: PT Kalbe Farma Tbk.

Capitalization 55,739B 3.31B 2.84B 2.65B 2.46B 4.59B 299B 4.95B 30.46B 11.97B 143B 12.4B 12.15B 526B P/E ratio 2025 *
16.1x
P/E ratio 2026 * 14.8x
Enterprise value 50.57B 3M 2.58M 2.4M 2.23M 4.17M 271M 4.49M 27.64M 10.86M 129M 11.25M 11.02M 478M EV / Sales 2025 *
1.45x
EV / Sales 2026 * 1.31x
Free-Float
40.21%
Yield 2025 *
2.92%
Yield 2026 * 3.25%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.82%
1 week+2.93%
Current month+2.07%
1 month+6.03%
3 months+13.36%
6 months-22.88%
Current year+2.07%
More quotes
1 week 1,180
Extreme 1180
1,235
1 month 1,165
Extreme 1165
1,255
Current year 1,180
Extreme 1180
1,240
1 year 985
Extreme 985
1,600
3 years 985
Extreme 985
2,360
5 years 985
Extreme 985
2,360
10 years 830
Extreme 830
2,360
More quotes
Manager TitleAgeSince
Chief Executive Officer 63 2024-05-15
Chief Tech/Sci/R&D Officer - -
Sales & Marketing 56 -
Director TitleAgeSince
Director/Board Member 61 2007-12-31
Chairman 61 2024-05-15
Director/Board Member 54 2015-05-17
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.82%+2.93%-2.77%-40.00% 3.31B
-0.35%+1.24%+35.07%+197.88% 964B
+1.87%+4.33%+47.89%+23.19% 515B
+0.32%-1.42%+24.90%+43.72% 390B
+0.95%+1.71%+30.60%+16.77% 363B
+1.96%+0.41%+34.36%+22.32% 292B
+1.87%+1.55%+28.02%+33.80% 272B
-0.85%-0.56%+7.21%-3.55% 269B
-1.40%+3.37%-36.05%-20.49% 265B
-0.38%-1.78%+20.03%+19.35% 175B
Average +0.39%+1.50%+18.93%+29.30% 350.84B
Weighted average by Cap. +0.34%+1.56%+26.46%+67.98%
See all sector performances

Financials

2025 *2026 *
Net sales 34,885B 2.07B 1.78B 1.66B 1.54B 2.88B 187B 3.1B 19.06B 7.49B 89.31B 7.76B 7.6B 329B 37,653B 2.23B 1.92B 1.79B 1.66B 3.1B 202B 3.35B 20.58B 8.08B 96.4B 8.38B 8.2B 356B
Net income 3,560B 211M 181M 169M 157M 293M 19.07B 316M 1.95B 764M 9.11B 792M 776M 33.62B 3,885B 230M 198M 185M 172M 320M 20.81B 345M 2.12B 834M 9.95B 864M 846M 36.68B
Net Debt -5,167B -306M -263M -246M -228M -426M -27.68B -459M -2.82B -1.11B -13.23B -1.15B -1.13B -48.78B -6,463B -383M -329M -307M -285M -533M -34.62B -574M -3.53B -1.39B -16.55B -1.44B -1.41B -61.02B
More financial data * Estimated data
Logo PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Employees
12,784
More about the company
Date Price Change Volume
26-01-14 1,230.00 Rp 0.00% 45,697,500
26-01-13 1,230.00 Rp +0.82% 39,389,900
26-01-12 1,220.00 Rp +2.95% 60,842,500
26-01-09 1,185.00 Rp -0.42% 19,865,000
26-01-08 1,190.00 Rp -0.42% 40,194,800

End-of-day quote INDONESIA S.E., January 12, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
1,230.00IDR
Average target price
1,685.00IDR
Spread / Average Target
+36.99%
Consensus

Quarterly revenue - Rate of surprise